Page Loading...
Layout Table~~~~1413~1413~~
Protein Microarrays: Technology Adoption & Utilization~
Published by Bioinformatics LLC, September 2005

As protein arrays have become more consistent and reliable, scientists have begun to incorporate them into their proteomics experiments. The technology's ability to detect protein expression more quickly and easily than traditional approaches has begun to transform the dream of characterizing an organism's entire collection of proteins (i.e., proteome) into reality through high throughput analysis. While there is tremendous excitement about the potential of protein arrays to further our understanding about protein function, there are also concerns over frustrating technical limitations.

~
Published by Bioinformatics LLC, September 2005

As protein arrays have become more consistent and reliable, scientists have begun to incorporate them into their proteomics experiments. The technology's ability to detect protein expression more quickly and easily than traditional approaches has begun to transform the dream of characterizing an organism's entire collection of proteins (i.e., proteome) into reality through high throughput analysis. While there is tremendous excitement about the potential of protein arrays to further our understanding about protein function, there are also concerns over frustrating technical limitations.

Based on a 39-question survey of scientists in the field of proteomics, Protein Microarrays: Technology Adoption & Utilization provides suppliers with insights into the types of products required to support this research. In order to benchmark the current state of the market for protein arrays, this report details researchers’ experimental parameters, current and future levels of sample throughput and choice of supplier. It reveals respondents’ satisfaction with their protein arrays, reagents and instrumentation, and determines the product attributes that are of the greatest importance, as well as areas where they perform above or below expectations. Additionally, the report explores why some proteomics researchers opt not to use protein arrays and what factors could influence scientists to begin using them.

The major objectives of this report are as follows:

~Protein Microarrays%3A Technology Adoption & Utilization%3A print copy|62|~1413~1708~~
Molecular Diagnostics~
Published by Select Biosciences, Spring 2005


The molecular diagnostics marketplace offers a growth opportunity given the interest in utilizing molecular tools to precisely target therapeutics.

This report analyzes the technologies and their impact in the molecular diagnostics marketplace. An assessment of all the technologies of value in this market and which market segments are impacted and affected by these technologies.

Furthermore, in this report are presented qualitative and quantitative market analysis of molecular diagnostics. Presented are total industry revenues, growth rates, and the various qualitative drivers that are contributing to the growth of the marketplace.
~Untitled DocumentPublished by Select Biosciences, Spring 2005

The molecular diagnostics marketplace offers a growth opportunity given the interest in utilizing molecular tools to precisely target therapeutics.

This report analyzes the technologies and their impact in the molecular diagnostics marketplace. An assessment of all the technologies of value in this market and which market segments are impacted and affected by these technologies.

Furthermore, in this report are presented qualitative and quantitative market analysis of molecular diagnostics. Presented are total industry revenues, growth rates, and the various qualitative drivers that are contributing to the growth of the marketplace.

Key Highlights of this Report:


• Qualitative and quantitative market analyses, and market forecasts
• Technology assessment and competitive analysis
• All the major technology platforms deployed in molecular diagnostics:
    o Instrumentation
    o Complete Assay Technologies
• Approval processes for molecular diagnostics for US, European Union, and Japan are presented. This is key information for new entrants into this marketplace.
• Segments of the molecular diagnostics marketplace
• Qualitative market drivers
• Quantitative Market Analysis
    o Total market size in terms of industry revenues and growth rate
    o Emerging market segments-and estimated market sizes
    o Growth areas in terms of classes of analytes-biological targets for development of molecular diagnostics



Table of contents | Sample Pages ~Molecular Diagnostics (single user print version)|757|Molecular Diagnostics (Eletronic site license PDF + One print Copy)|758|~1413~2607~~
Protein Crystallography~
Strategic Opportunities

Published by Select Biosciences, June 2004

A detailed market review and thorough analysis of the technologies and business strategies of 28 leading companies in this field is presented in this new report from Select Biosciences. Authored by a panel of industry experts, it is believed to be the first business report of its kind on Protein Crystallography. Based on extensive primary and secondary research it illustrates strategic opportunities for technology and tools vendors.~Strategic Opportunities

Published by Select Biosciences, June 2004

A detailed market review and thorough analysis of the technologies and business strategies of 28 leading companies in this field is presented in this new report from Select Biosciences. Authored by a panel of industry experts, it is believed to be the first business report of its kind on Protein Crystallography. Based on extensive primary and secondary research it illustrates strategic opportunities for technology and tools vendors.This report includes



Table of Contents
~Protein Crystallography%3A Full report- single user print version|64|Protein Crystallography%3A Full report -PDF site license + 1 print copy|697|~1413~1706~~
Tissue Microarrays~
Published by Select Biosciences, May 2004

The report provides in-depth information on the market and size segmented by technology and application. In addition to a detailed market model, Tissue Microarrays : Market Assessment and Opportunities evaluates the strengths and weaknesses of each of the TMA vendors, and assesses both opportunities and threats facing their products & services. The companies most likely to dominate specific market segments, as well as the companies most likely to play key supporting roles in moving technologies forward are identified.~Published by Select Biosciences, May 2004


The report provides in-depth information on the market and size segmented by technology and application. In addition to a detailed market model, Tissue Microarrays : Market Assessment and Opportunities evaluates the strengths and weaknesses of each of the TMA vendors, and assesses both opportunities and threats facing their products & services. The companies most likely to dominate specific market segments, as well as the companies most likely to play key supporting roles in moving technologies forward are identified.


View Full Table of Contents~Tissue Microarrays%3A Full Report - Single user print version|61|Tissue Microarrays%3A Full Report - PDF site License +1 print copy|696|~1413~1711~~
Proteomics~
Published by Select Biosciences, July 2003

The proteomics market grew from $1.1 billion in 2001 to almost $1.4 billion in 2002 and, based on first quarter numbers, the growth rate is continuing in 2003. But the success is creating a bottleneck. High-throughput and/or high-output technologies are used to discover potential biomarkers and drug targets, but the validation methods are low-throughput and low-output. For proteomics to continue its current growth rate, the industry needs new methods and technologies to speed validation. Fortunately, multiple emerging technologies are poised to meet this need.

The report, Proteomics 2003, presents detailed interviews with proteomics experts, thorough evaluations of 75 leading proteomics companies in the United States and Europe, three scenarios for the future of the industry, and a quantitative market model. The analysis is based on extensive research that includes dozens of interviews with current and potential customers and with company representatives.

~Published by Select Biosciences, July 2003

The proteomics market grew from $1.1 billion in 2001 to almost $1.4 billion in 2002 and, based on first quarter numbers, the growth rate is continuing in 2003. But the success is creating a bottleneck. High-throughput and/or high-output technologies are used to discover potential biomarkers and drug targets, but the validation methods are low-throughput and low-output. For proteomics to continue its current growth rate, the industry needs new methods and technologies to speed validation. Fortunately, multiple emerging technologies are poised to meet this need.

The report, Proteomics 2003, presents detailed interviews with proteomics experts, thorough evaluations of 75 leading proteomics companies in the United States and Europe, three scenarios for the future of the industry, and a quantitative market model. The analysis is based on extensive research that includes dozens of interviews with current and potential customers and with company representatives.

More Information~Full Report - Single User Print Version|117|Full Report - PDF Site License + 1 Print Copy|698|~1413~1483~~
Protein Biochips 2003~
Published by BioPerspectives, April 2003

The protein biochip market is underserved, despite growing from $70 million in 2001 to $100 million in 2002. The market is projected to grow to more than $400 million in 2007, a compound annual growth rate of more than 35%. Prepared in partnership with BioInsights, this report presents a detailed market model and thorough analysis of the technologies and business strategies of nearly 40 leading protein biochip companies.~Published by BioPerspectives, April 2003

The protein biochip market is underserved, despite growing from $70 million in 2001 to $100 million in 2002. The market is projected to grow to more than $400 million in 2007, a compound annual growth rate of more than 35%. Prepared in partnership with BioInsights, this report presents a detailed market model and thorough analysis of the technologies and business strategies of nearly 40 leading protein biochip companies. This report is available as a print version or electronic (supplied as pdf) site license (price includes one print copy).
~Protein Biochips 2003%3A Single user print version|59|Protein Biochips 2003%3A Electronic site license (pdf)|695|~1413~1712~~
Menu Page | Toolbar Page |
Frameset Page | Index Page | Table of Contents
EROL - Electronic Retail Online E-commerce shopping cart software